MYX mayne pharma group limited
Add to My Watchlist 1.34% ! $5.29

What MYX chart shouts, page-249

  1. newB
    7,701 Posts.
    lightbulb Created with Sketch. 630
    clock Created with Sketch.
    23/08/24
    15:42
    Post #: 75345902
    Mayne Pharma has MC of $371m and revenue of $388m, making the ration less than 1!
    Imaging if they can make breakeven profitability the share will fly

    this is a major turning around story!
    Last edited by newB: 23/08/24
    MYX Price at posting: $4.40 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
LU7 Lithium Universe Acquires Global Rights to Transformative Solar Panel Recycling Technology
right-arrow Created with Sketch.
NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.29 		Change
0.070(1.34%) 		Mkt cap ! $429.7M
Open High Low Value Volume
$5.29 $5.33 $5.15 $291.0K 55.15K

Buyers (Bids)

No. Vol. Price($)
7 403 $5.29
 

Sellers (Offers)

Price($) Vol. No.
$5.31 129 5
View Market Depth
Last trade - 13.49pm 18/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.